Advertisement
Advertisement
TECH
Bio-Techne Corp.
72.32
USDSponsored
+0.04
+0.06%
Aug 21, 15:59 UTC -4
Closed
After-Market
72.28
-0.03
-0.05%
TECH Earnings Reports
Positive Surprise Ratio
TECH beat 25 of 41 last estimates.
61%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q1 27 (Revenue/ EPS)
$297.59M
/$0.45
Implied change from Q4 26 (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
+3.85%
/+7.14%
Bio-Techne Corp. earnings per share and revenue
On Aug 11, 2026, TECH reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of 0.52 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 320.97 million, with a --% difference. The market reacted with a +0.11% price change (close before vs. close after earnings).
Looking ahead to Q1 27, -- analysts forecast an EPS of 0.45 USD, with revenue projected to reach 297.59 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
CorMedix Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.24
Actual
$0.28
Surprise
+19.44%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Fate Therapeutics, Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.25
Surprise
+8.49%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
MiNK Therapeutics, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.61
Actual
-$0.62
Surprise
-1.31%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
Kyntra Bio, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$3.24
Actual
-$4.68
Surprise
-44.15%
Beyond Air, Inc. Common Stock
Report Date
Aug 13, 2026 For Q1 27
Estimate
-$11.01
Actual
-$11.00
Surprise
+0.15%
FAQ
What were Bio-Techne Corp.'s earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Bio-Techne Corp. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Bio-Techne Corp.'s Q4 2026 earnings?
The stock price moved up 0.11%, changed from $72.15 before the earnings release to $72.23 the day after.
When is Bio-Techne Corp. expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Bio-Techne Corp.'s next earnings report?
Based on --
analysts, Bio-Techne Corp. is expected to report EPS of $0.45 and revenue of $297.59M for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement